JP2018531578A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531578A5 JP2018531578A5 JP2017560329A JP2017560329A JP2018531578A5 JP 2018531578 A5 JP2018531578 A5 JP 2018531578A5 JP 2017560329 A JP2017560329 A JP 2017560329A JP 2017560329 A JP2017560329 A JP 2017560329A JP 2018531578 A5 JP2018531578 A5 JP 2018531578A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- virus
- influenza
- influenza virus
- attenuated influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2015147703 | 2015-11-06 | ||
| RU2015147703A RU2628690C2 (ru) | 2015-11-06 | 2015-11-06 | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
| PCT/RU2016/050066 WO2017078577A2 (ru) | 2015-11-06 | 2016-11-03 | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531578A JP2018531578A (ja) | 2018-11-01 |
| JP2018531578A5 true JP2018531578A5 (https=) | 2019-10-31 |
| JP6692835B2 JP6692835B2 (ja) | 2020-05-13 |
Family
ID=58662984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017560329A Active JP6692835B2 (ja) | 2015-11-06 | 2016-11-03 | 感染性疾患の予防及び／又は処置並びに腫瘍性疾患の処置のための弱毒化インフルエンザベクター |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10392604B2 (https=) |
| EP (1) | EP3382010A4 (https=) |
| JP (1) | JP6692835B2 (https=) |
| KR (1) | KR102604877B1 (https=) |
| CN (1) | CN108026515B (https=) |
| AU (1) | AU2016350939B9 (https=) |
| CA (1) | CA2991023C (https=) |
| CU (1) | CU24580B1 (https=) |
| IL (1) | IL255259B (https=) |
| MA (1) | MA43314A (https=) |
| MX (1) | MX380393B (https=) |
| RU (1) | RU2628690C2 (https=) |
| SG (1) | SG11201709122VA (https=) |
| UA (1) | UA125333C2 (https=) |
| WO (1) | WO2017078577A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3632433B1 (en) * | 2017-05-26 | 2025-12-24 | Vladimir Evgenievich Nebolsin | Novel glutaminyl cyclase inhibitors and the use thereof in treatment of various diseases |
| US12178869B2 (en) * | 2017-12-22 | 2024-12-31 | Codagenix Inc. | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| CN111315407B (zh) | 2018-09-11 | 2023-05-02 | 上海市公共卫生临床中心 | 一种广谱抗流感疫苗免疫原及其应用 |
| KR102370100B1 (ko) * | 2019-02-15 | 2022-03-07 | 아이디바이오 주식회사 | 이종 인플루엔자 a 바이러스에 대한 면역/치료반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 유전자 전달체 및 치료백신 |
| RU2726106C1 (ru) * | 2019-07-18 | 2020-07-09 | федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ гриппа им. А.А. Смородинцева" Минздрава России) | Рекомбинантный штамм вируса гриппа A/PR8-NS124-TB10.4-2A-HspX и способ специфической профилактики туберкулеза легких с использованием вакцины мукозального применения на его основе |
| AU2021342299A1 (en) * | 2020-09-11 | 2023-04-13 | The United States Of America, As Represented By The Secretary Of Agriculture | Compositions and methods of use thereof for prevention and treatment of influenza infections |
| US12440553B2 (en) * | 2020-11-11 | 2025-10-14 | California Institute Of Technology | Multivalent carriers and related vaccine compositions |
| CN113430178B (zh) * | 2021-06-21 | 2022-10-11 | 武汉大学 | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 |
| WO2025041889A1 (ko) * | 2023-08-24 | 2025-02-27 | 성신여자대학교 연구산학협력단 | 외래 항원을 발현하는 재조합 인플루엔자 바이러스 벡터 및 이를 포함하는 백신 조성물 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4837827B2 (ja) * | 1998-06-12 | 2011-12-14 | マウント シナイ スクール オブ メディシン | 新規なウイルス増殖方法およびそのためのインターフェロン欠損培養基 |
| DE69937999T2 (de) * | 1998-06-12 | 2009-01-29 | Avir Green Hills Biotechnology Research Development Trade Ag | Interferon induzierende genetisch veränderte attenuierte viren |
| WO2001064860A2 (en) * | 2000-03-02 | 2001-09-07 | Polymun Scientific Immunbiologische Forschung Gmbh | Recombinant influenza a viruses |
| US7037707B2 (en) * | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
| US7709190B2 (en) * | 2005-12-02 | 2010-05-04 | Board Of Regents, The University Of Texas System | Influenza A virus vaccines and inhibitors |
| EP2048237A1 (en) | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
| EP2072058A1 (en) * | 2007-12-21 | 2009-06-24 | Avir Green Hills Biotechnology Research Development Trade Ag | Modified influenza virus |
| US9217157B2 (en) * | 2009-07-27 | 2015-12-22 | Icahn School Of Medicine At Mount Sinai | Recombinant influenza viruses and uses thereof |
| US8828406B2 (en) * | 2009-07-30 | 2014-09-09 | Icahn School Of Medicine At Mount Sinai | Influenza viruses and uses thereof |
| WO2011130652A2 (en) * | 2010-04-15 | 2011-10-20 | George Baer | Compositions and methods for vaccinating humans and animals against enveloped viruses |
| JP2013531496A (ja) * | 2010-06-06 | 2013-08-08 | モウント シナイ スクール オフ メディシネ | 組換えｒｎａウイルス及びその使用 |
| EP2646459B1 (en) * | 2010-12-02 | 2020-01-08 | Bionor Immuno AS | Peptide scaffold design |
| EP2708552A1 (en) * | 2012-09-12 | 2014-03-19 | Medizinische Universität Wien | Influenza virus |
-
2015
- 2015-11-06 RU RU2015147703A patent/RU2628690C2/ru active
-
2016
- 2016-11-03 US US15/566,202 patent/US10392604B2/en active Active
- 2016-11-03 EP EP16862552.3A patent/EP3382010A4/en active Pending
- 2016-11-03 WO PCT/RU2016/050066 patent/WO2017078577A2/ru not_active Ceased
- 2016-11-03 MA MA043314A patent/MA43314A/fr unknown
- 2016-11-03 CA CA2991023A patent/CA2991023C/en active Active
- 2016-11-03 CU CU2018000035A patent/CU24580B1/es unknown
- 2016-11-03 CN CN201680033797.2A patent/CN108026515B/zh active Active
- 2016-11-03 MX MX2017015462A patent/MX380393B/es unknown
- 2016-11-03 KR KR1020177036573A patent/KR102604877B1/ko active Active
- 2016-11-03 JP JP2017560329A patent/JP6692835B2/ja active Active
- 2016-11-03 SG SG11201709122VA patent/SG11201709122VA/en unknown
- 2016-11-03 UA UAA201709223A patent/UA125333C2/uk unknown
- 2016-11-03 AU AU2016350939A patent/AU2016350939B9/en active Active
-
2017
- 2017-10-25 IL IL255259A patent/IL255259B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018531578A5 (https=) | ||
| RU2015147703A (ru) | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний | |
| Elkashif et al. | Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections | |
| Wang et al. | Protective efficacy of the conserved NP, PB1, and M1 proteins as immunogens in DNA-and vaccinia virus-based universal influenza A virus vaccines in mice | |
| JP2019537424A5 (https=) | ||
| Ibañez et al. | M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A | |
| RU2014117068A (ru) | Вакцина на основе рекомбинантных наночастиц f из rsv против респираторно-синцитиального вируса | |
| JP2013518052A5 (https=) | ||
| Bolduc et al. | The quest for a nanoparticle-based vaccine inducing broad protection to influenza viruses | |
| TW202430206A (zh) | 組合疫苗 | |
| US20230210980A1 (en) | Chimeric adenoviral vectors | |
| Kopecky-Bromberg et al. | Recombinant vectors as influenza vaccines | |
| Kesik-Brodacka et al. | A universal flu vaccine | |
| Lim et al. | RNA-dependent assembly of chimeric antigen nanoparticles as an efficient H5N1 pre-pandemic vaccine platform | |
| JP7602457B2 (ja) | ペプチド核酸を基盤としたアジュバント | |
| Kim et al. | Generation of VHSV replicon particles carrying transmembrane and C-terminal cytoplasmic region-deleted G gene (rVHSV-GΔTM) and comparison of vaccine efficacy with G gene-deleted VHSV (rVHSV-ΔG) | |
| Geeraedts et al. | Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine | |
| Chang et al. | A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus | |
| US20240093234A1 (en) | Chimeric adenoviral vectors | |
| Attaran et al. | Immunogenicity and protective efficacy of recombinant M2e. Hsp70c (Hsp70359–610) fusion protein against influenza virus infection in mice | |
| US20250049912A1 (en) | Multicistronic Vaccine and Methods for Producing and Using the Same | |
| RU2016111907A (ru) | Аттенуированный гриппозный вектор и мукозальная универсальная гриппозная вакцина на его основе | |
| Tang et al. | Combating respiratory diseases with mucosal vaccines | |
| Ashraf et al. | COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines 2021, 9, 171 | |
| Fusheng | Targeting COVID-19, MERS, and SARS with a Universal Vaccine Strategy |